血浆尿酸与帕金森病风险:一项孟德尔随机化研究
在哥本哈根一般人群研究超过102,000人中,采用观察性和遗传学分析(SLC2A9 rs7442295和ABCG2 rs2231142)检验高血浆尿酸与低帕金森病发病率的关联。观察性分析显示最高三分位尿酸组风险降低(HR 0.56),但工具变量分析未显示因果关联(OR 1.20),数据不支持高尿酸与低帕金森病风险的因果关系。
要点
- 观察性分析中最高三分位血浆尿酸与帕金森病风险降低相关(HR 0.56,95%CI 0.41-0.77,趋势P=8×10^-5)。
- 工具变量分析中血浆尿酸每升高50μmol/l对应帕金森病OR 1.20(95%CI 0.85-1.71),无显著关联。
- 作者结论认为数据不支持高血浆尿酸与低帕金森病风险之间的因果关系。
核心结论
- 观察性分析显示高血浆尿酸与较低帕金森病风险相关,但工具变量分析未显示此关联,数据不支持因果关系。
研究设计与样本
- 研究使用哥本哈根一般人群研究中超过102,000人的血浆尿酸及SLC2A9 rs7442295和ABCG2 rs2231142基因型进行观察性和遗传学分析。
- 帕金森病发病和死亡信息来自国家患者和死亡登记库,采用Cox回归、Fine和Gray竞争风险回归及工具变量分析计算发病率。
主要发现
- 共398人被诊断为帕金森病,其中285例为 incident 病例。
- 血浆尿酸最高三分位组与最低三分位组相比,帕金森病多变量校正风险比HR 0.56(95%CI 0.41-0.77),三组趋势P=8×10^-5。
- 联合等位基因评分每增加一个等位基因,血浆尿酸升高19μmol/l(95%CI 18.5-19.9)。
- 观察性分析中血浆尿酸每升高50μmol/l,帕金森病风险比HR 0.85(95%CI 0.77-0.92)。
- 工具变量分析中血浆尿酸每升高50μmol/l,帕金森病比值比OR 1.20(95%CI 0.85-1.71)。
关键数值与推荐
- 血浆尿酸最高三分位组 vs 最低三分位组:帕金森病多变量校正HR 0.56(95%CI 0.41-0.77)。
- 联合等位基因评分每增加一个等位基因:血浆尿酸升高19μmol/l(95%CI 18.5-19.9)。
- 血浆尿酸每升高50μmol/l:观察性分析HR 0.85(95%CI 0.77-0.92);工具变量分析OR 1.20(95%CI 0.85-1.71)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Urate is a potent antioxidant, and high plasma urate has been associated with lower incidence of Parkinson's disease (PD) in epidemiological studies. We tested the hypothesis that high concentrations of plasma urate are associated with low incidence of PD. METHODS: We performed observational and genetic analyses using plasma urate and the urate SLC2A9 rs7442295 and ABCG2 rs2231142 genotype in >102,000 individuals from the CGPS (Copenhagen General Population Study). Information on PD and mortality was from national patient and death registries. Incidences of PD were calculated using Cox regression, Fine and Gray competing-risks regression, and instrumental variable analyses. RESULTS: In total, 398 individuals were diagnosed with PD, of which 285 were incident cases. The multivariable adjusted hazard ratio for PD was 0.56 (95% confidence interval [CI], 0.41-0.77) for the highest versus the lowest tertile of plasma urate (p for trend across 3 groups, 8 × 10-5 ). Each one-allele increase in the combined allele score was associated with 19μmol/l (95% CI, 18.5-19.9) higher plasma urate. In observational analyses, a 50μmol/l higher plasma urate was associated with a hazard ratio of 0.85 (0.77-0.92) for PD; in instrumental variable analyses, 50μmol/l higher plasma urate was associated with an odds ratio of 1.20 (0.85-1.71) for PD. INTERPRETATION: High plasma urate was associated with lower risk of PD in observational analyses; however, in instrumental variable analysis, high plasma urate was not associated with low risk of PD. Thus, our data do not support a causal relationship between high plasma urate and low risk of PD. Ann Neurol 2018;84:178-190.
引用
- Kobylecki CJ, Nordestgaard BG, Afzal S, et al. Plasma urate and risk of Parkinson's disease: A mendelian randomization study. Ann Neurol. 2018. PMID: 30014508. doi:10.1002/ana.25292
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。